Table 3.

Clinical data for penile cancer patients treated with postoperative RT.

Patient No.	Stage	RT dose (Gy)	Concurrent Chemotherapy	Patterns of failure	Time to failure since completion of RT (Months)	Follow-up (Months)	GARD
1	pT3 N2	50	N	RR and DM	1.28 and 1.28, respectively	5.1	19.51
2	pT1 N2	45	Y	RR	14.54	15.6	20.52
3	pT2 N2	46	Y	RR and DM	0.82 and 1.41, respectively	4.4	16.19
4	pT1 N3	50.4	Y			24.4	20.98
5	pT3 N2	45	Y			10.3	34.90
6	pT1 N3	45	Y	LR	2.57	30.0	18.57
7	pT3 N2	50	Y			12.1	20.77
8	pT3 N2	50.4	Y			64.5	38.39
9	pT3 N3	50	Y	LR and RR	37.43	84.6	14.52
10	pT3 N2	45	Y			16.9	16.05
11	pT1aN2	59.4	Y	RR	4.51	11.3	N/A
12	pT2 N2	53.75	N			18.5	N/A
13	pT2 N2	50	Y			43.6	N/A
14	pT1 N3	50	Y	RR	Recurrence during RT	19.2	N/A
15	pT3 N3	46	Y	LR	Progression during RT	6.4	N/A
16	pT3 N3	53.75	Y			9.6	N/A
17	pT2 N2	57.4	Y	LR	6.12	23.3	N/A
18	pT1 N2	53.75	Y			4.2	N/A
19	pT1 N2	54	Y	RR	5.69	10.8	N/A
20	pT1 N3	64.8	Y			49.7	N/A
21	pT2 N3	50	Y			44.7	N/A
22	pT2 N2	45	Y	LR and DM	12.01 and 12.01, respectively	17.1	N/A
23	pT2 N0	45	N			6.7	N/A
24	pT1 N2	60	Y	DM	1.02	58.8	N/A
25	pT3 N1	45	Y			34.4	N/A
26	pT4 Nx	50.4	Y			0.7	N/A
27	pT2 N1	45	Y			104.7	N/A
28	pT2 N2	50	Y			3.5	N/A
29	pT2 N2	59.4	Y	RR	3.75	9.1	N/A
30	pT1 N2	50.4	Y			5.6	N/A
31	pT1 N2	42.5	Y			27.9	N/A
32	pT2 N2	50	Y			2.8	N/A
33	pT2 N2	50	N	RR	7.99	28.8	N/A
34	pT3 N2	63	Y	RR	0.16	6.3	N/A

Abbreviations: RT = Radiation therapy; LR = Local recurrence; RR = Regional recurrence; DM = Distant metastasis.